1. Home
  2. LIXT vs GV Comparison

LIXT vs GV Comparison

Compare LIXT & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • GV
  • Stock Information
  • Founded
  • LIXT 2005
  • GV 2013
  • Country
  • LIXT United States
  • GV Canada
  • Employees
  • LIXT N/A
  • GV N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • LIXT Health Care
  • GV Real Estate
  • Exchange
  • LIXT Nasdaq
  • GV Nasdaq
  • Market Cap
  • LIXT 6.3M
  • GV 5.8M
  • IPO Year
  • LIXT N/A
  • GV 2022
  • Fundamental
  • Price
  • LIXT $1.27
  • GV $1.56
  • Analyst Decision
  • LIXT
  • GV
  • Analyst Count
  • LIXT 0
  • GV 0
  • Target Price
  • LIXT N/A
  • GV N/A
  • AVG Volume (30 Days)
  • LIXT 155.3K
  • GV 63.7K
  • Earning Date
  • LIXT 03-18-2025
  • GV 03-04-2025
  • Dividend Yield
  • LIXT N/A
  • GV N/A
  • EPS Growth
  • LIXT N/A
  • GV N/A
  • EPS
  • LIXT N/A
  • GV 0.32
  • Revenue
  • LIXT N/A
  • GV $9,380,985.00
  • Revenue This Year
  • LIXT N/A
  • GV N/A
  • Revenue Next Year
  • LIXT N/A
  • GV N/A
  • P/E Ratio
  • LIXT N/A
  • GV $5.30
  • Revenue Growth
  • LIXT N/A
  • GV 11.25
  • 52 Week Low
  • LIXT $1.25
  • GV $1.00
  • 52 Week High
  • LIXT $4.40
  • GV $8.85
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 28.82
  • GV 42.36
  • Support Level
  • LIXT $1.35
  • GV $1.38
  • Resistance Level
  • LIXT $3.00
  • GV $1.80
  • Average True Range (ATR)
  • LIXT 0.26
  • GV 0.17
  • MACD
  • LIXT -0.13
  • GV 0.01
  • Stochastic Oscillator
  • LIXT 1.15
  • GV 50.98

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: